Heart Failure Management: Health Equity and Access to Care

09/20/22 • 25 min

CE contact hours are no longer available for the content covered in this podcast episode. Check out the online library at pcna.net for up-to-date CE offerings.

Health equity issues, including access ot medications, significantly impact patients with heart failure. From pharmacy deserts to non-medical switching and beyond, hear strategies to assist patients in getting the medications they need, from nurses Binu Koirala, PhD, MGS, RN, with the Johns Hopkins University School of Nursing in Baltimore, and Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California.

Access to Innovative Medicines Provider Tools: https://pcna.net/clinical-resources/provider-tools/access-for-innovative-medicines-provider-tools/

Medicare State Pharmaceutical Assistance Program: medicare.gov/pharmaceutical-assistance-program/#state-programs

Extra Help with Medicare Prescription Drug Care Costss: ssa.gov/benefits/medicare/prescriptionhelp.html

CoverMyMeds: covermymeds.com/main/

Solving Medication Access issues: acc.org/latest-in-cardiology/articles/2020/10/01/01/42/feature-advancing-health-equity-for-heart-failure-patients

Non-Medical Switching: cga.ct.gov/2017/rpt/2017-R-0008.htm#:~:text=%E2%80%9CNon%2Dmedical%20switching%E2%80%9D%20broadly,expensive%20but%20therapeutically%20equivalent%20drug

Health Equity: cdc.gov/chronicdisease/healthequity/index.htm

Understanding Copay Accumulators: https://infusioncenter.org/understanding-copay-accumulators-who-really-benefits/

PACH (Partnership to Advance Cardovascular Health): advancecardiohealth.org/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

CE contact hours are no longer available for the content covered in this podcast episode. Check out the online library at pcna.net for up-to-date CE offerings.

Access to Innovative Medicines Provider Tools: https://pcna.net/clinical-resources/provider-tools/access-for-innovative-medicines-provider-tools/

Medicare State Pharmaceutical Assistance Program: medicare.gov/pharmaceutical-assistance-program/#state-programs

Extra Help with Medicare Prescription Drug Care Costss: ssa.gov/benefits/medicare/prescriptionhelp.html

CoverMyMeds: covermymeds.com/main/

Solving Medication Access issues: acc.org/latest-in-cardiology/articles/2020/10/01/01/42/feature-advancing-health-equity-for-heart-failure-patients

Non-Medical Switching: cga.ct.gov/2017/rpt/2017-R-0008.htm#:~:text=%E2%80%9CNon%2Dmedical%20switching%E2%80%9D%20broadly,expensive%20but%20therapeutically%20equivalent%20drug

Health Equity: cdc.gov/chronicdisease/healthequity/index.htm

Understanding Copay Accumulators: https://infusioncenter.org/understanding-copay-accumulators-who-really-benefits/

PACH (Partnership to Advance Cardovascular Health): advancecardiohealth.org/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Previous Episode

Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action

CE contact hours are no longer available for the content covered in this podcast episode. Check out the online library at pcna.net for up-to-date CE offerings.

Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renalprotective properties. Guests: Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.

2022 AHA/ACC/HFSA 2022 Guideline for the Managment of HF: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063

Pocket Guide: Guidelines for Managing CVD Risk in Patients with Diabetes: https://pcna.net/clinical-resources/provider-tools/diabetes-provider-tools/

HF Pocket Guide: A Guide to Prevention and Management: https://pcna.net/clinical-resources/provider-tools/heart-failure-provider-tools/

New and Emerging Treatments for Heart Failure: HFrEF and HFpEF (CE course): https://pcna.net/online-course/new-and-emerging-treatments-for-heart-failure-hfref-and-hfpef/

SGLT2is in Heart Failure: ncbi.nlm.nih.gov/pmc/articles/PMC8654149/

SGLT2i in HFpEF: multicenter randomized trial: nature.com/articles/s41591-021-01536-x

Empagliflozin in HFpEF: https://www.nejm.org/doi/10.1056/NEJMoa2107038#:~:text=Empagliflozin%20in%20HF%20with%20Preserved%20Ejection%20Fraction&text=Sodium%E2%80%93glucose%20cotransporter%202%20(SGLT2,and%20a%20reduced%20ejection%20fraction.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Next Episode

Heart Failure Management: Lifestyle and Self-Care

CE contact hours are no longer available for the content covered in this podcast episode. Check out the online library at pcna.net for up-to-date CE offerings.

Improving quality of life for patients with heart failure can include lifestyle modifications and require successful behavior change strategies. Learn best practices to apply into your clinical setting from nurse providers Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, of the University of Colorado in Denver, and Binu Koirala, PhD, MGS, RN, of the Johns Hopkins University School of Nursing in Baltimore.

PCNA Behavior Change mini-certifice (CE course): https://pcna.net/professional-development/online-learning/ "Behavior Change mini-certificate"

AHA HF Tools & Resources: heart.org/en/health-topics/heart-failure/heart-failure-tools-resources

Adherence to Healthy Sleep Patterns: ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050792?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&

Addressing Social Determinants of Health in Patients with HF: ahajournals.org/doi/10.1161/CIR.0000000000000767

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.